— Know what they know.
Not Investment Advice
Also trades as: BFRI (NASDAQ) · $vol 0M

BFRIW NASDAQ

Biofrontera Inc.
1W: -66.2% 1M: -72.5% 3M: -89.2% YTD: -92.0% 1Y: -93.5% 3Y: -99.5%
$0.01
-0.00 (-30.61%)
 
Weekly Expected Move ±28.0%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Pharmaceuticals · Tech Score Strong Sell · Power 34 · $3.9M mcap · 11M float · 0.035% daily turnover · Short 66% of daily vol

Balance Sheet Trends

Total Assets
$29M +29.2% ▲
5Y CAGR: +3.4%
Total Liabilities
$18M +2.4% ▲
5Y CAGR: -0.2%
Shareholders Equity
$10M +136.4% ▲
5Y CAGR: +12.5%
Cash & Investments
$6M +8.1% ▲
5Y CAGR: -4.6%
Total Debt
$6M +25.2% ▲
Net Debt
-$231K +76.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$25M$17M$1M$6M$6M
Short-Term Investments$0$11M$78K$7K$9K
Cash & ST Investments$25M$28M$1M$6M$6M
Net Receivables$4M$7M$5M$5M$7M
Inventory$4M$7M$11M$7M$1M
Other Current Assets$13M$286K$5M$3M$3M
Total Current Assets$46M$43M$23M$21M$18M
Property, Plant & Equip.$267K$2M$2M$983K$4M
Goodwill & Intangibles$3M$3M$3M$35K$3M
Long-Term Investments$3M$0$0$0$200K
Other Non-Current Assets$3M$3M$482K$383K$4M
Total Non-Current Assets$7M$8M$5M$1M$10M
Total Assets$53M$51M$28M$22M$29M
— Liabilities —
Accounts Payable$658K$1M$9M$2M$7M
Short-Term Debt$0$0$4M$0$332K
Deferred Revenue$3M$7M$0$0$0
Other Current Liabilities$7M$3M$3M$1M$5M
Total Current Liabilities$14M$21M$18M$12M$12M
Long-Term Debt$0$0$0$4M$6M
Other Non-Current Liab.$19M$3M$4M$1M$360K
Total Non-Current Liabilities$28M$6M$5M$6M$6M
Total Liabilities$42M$27M$23M$18M$18M
— Equity —
Common Stock$17K$1K$2K$9K$12K
Retained Earnings-$79M-$80M-$100M-$117M-$128M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$11M$24M$5M$4M$10M
Total Liabilities & Equity$53M$51M$28M$22M$29M
— Key Metrics —
Total Debt$0$1M$5M$5M$6M
Net Debt-$25M-$16M$4M-$983K-$231K
Total Investments$3M$11M$78K$7K$209K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms